MLS® Laser Therapy and Hilterapia®: awards in Russia

21 February 2012 - Corporate -

The hospital in Moscow "Dikul", specialized in orthopedics and rehabilitation, and the "Moscow University Municipal Hospital 31" were the venues of the continuous education centered on MLS® Laser Therapy and Hilterapia® kept by the staff of ASAlaser led by Lucio Zaghetto (CEO ASAlaser). 

Participants, after having taken part in a course dedicated to Hilterapia® last December, are now confronting with the MLS® Laser Therapy, testing the concrete benefits. 

"The 10 participants to "Master Class Hilterapia® and MLS®" - explains Lucio Zaghetto - after observing the absolute effectiveness of Hilterapia® compared to other therapeutic techniques, have now understood the importance of integrating it with the MLS®. In fact, if MLS® Laser Therapy is optimal for the resolution of diseases involving shallow areas, such as the neck pain, Hilterapia® is the most suitable solution to act in depth. ASAlaser objective is indeed to provide the most effective, safe and fast therapy to solve specific diseases". 

The interest shown for the two treatments has kept pace with that for technical and scientific innovations that underlie them. "Following the "preliminary" course, viewing the different treatment protocols and related clinical research and seeing live results obtained with the first session conducted by their colleagues, the course participants showed amazement and curiosity up to wishing to investigate at once the application of the two therapies in the resolution of many illnesses. On the strength on these results, we will continue our program of continuous training, possibly in association with our courses online that aroused great appeal among people attending the "Master Class"". 

Two of the most popular medical centers in Russia as well recognize the effectiveness of MLS® Laser Therapy and Hilterapia® confirming the success already collected in many Countries in the world including the United States. "A further confirmation of the interest for our therapies was obtained partecipating to the congress "Traumatology and orthopedics. Present and Future" in Moscow where our devices have attracted the attention of professionals".

 

You might also be interested in ...

See all articles

M-Hi All Terrain
News - 12/03/2025
M-Hi All Terrain redefines the standards of MLS® Laser Therapy, combining portability, resistance and operational autonomy to offer effective treatments anywhere.
2024 ASAlaser activities
News - 11/12/2024
Whether it’s by taking part in Congresses and Fairs or organising on-site courses or webinars, once again in 2024 ASA has proved to be highly proactive in both the human and veterinary fields.
El.En. e ASA unite nello sviluppo tecnologico
News - 09/12/2024
Research and Development are the pillars on which all the companies of the El.En. Group base their growth: technological innovation, continuous training and know-how sharing are the key words that...
MLS Laser Therapy for TMD
Blog - 22/10/2025
A recent publication from Chulalongkorn University (Thailand) demonstrated how an integrated and conservative approach, supported by MLS® Laser Therapy, can offer highly effective clinical results.
M-Hi laser training UK
News - 22/10/2025
From 30 September to 3 October, the tour visited three cities in the United Kingdom, involving physiotherapists and specialists who have chosen the M-Hi and HIRO TT laser systems.
Press - 07/10/2025
Recent research and pilot studies highlight the benefits of laser therapy in treating radiodermatitis and peripheral neuropathy induced by radiation and chemotherapy for breast cancer.